PTC Therapeutics Receives Complete Response Letter for Vatiquinone NDA
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/15/2026
- S&P 500, Nasdaq pare declines as AI rout teeters; healthcare, staples gain
- U.S. producer prices rise by 1.3% month-on-month in September
- Brent steady as US weighs easing sanctions on global 'shadow fleet'
- UBS now expects a third Fed rate hike after hot September inflation print
- Tesla-SpaceX Merger could be announced before December, Barclays says
| PTC THERAPEUTICS (NASDAQ: PTCT) | Delayed: 61.18 +1.51 (2.53%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $59.67 | 52 Week High | $35.40 | |||
| Open | $61.08 | 52 Week Low | $4.03 | |||
| Day High | $62.31 | P/E | 6.51 | |||
| Day Low | $59.88 | EPS | $9.40 | |||
| Volume | 395,407 | |||||
